Healthy adults
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with no history of psychiatric disorders. Subjects with normal BMI (18.5-25) Subjects who have the ability to provide informed consent and adhere to the protocol.
Exclusion criteria
Exclusion criteria: Subjects with drug allergy. Subjects taking drugs within 2 weeks of the trial. Subjects with hyperthyroidism, hypertension, heart disease, diabetes, severe asthma or hypoxemia. Pregnant woman, woman suspected of being pregnant, or lactating woman. Subject who is contraindicated for the use of MRI. Subjects taking caffeine 2 days before or alcohol the day before the trial. Subjects who are judged as not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BOLD signal changes measured by fMRI | — |
Countries
Japan
Contacts
Nippon Medical School Department of Pharmacology